SONOVA (SONVY) Stock Price, News & Analysis

Company Overview

Sonova Holding AG, trading under the symbol SONVY on the OTCMKTS, is a Switzerland‐based global leader in the design, manufacture and distribution of hearing care solutions. Since its founding in 1947, Sonova has focused on developing innovative hearing instruments and implantable devices to improve auditory function and quality of life for individuals with hearing loss. The company’s core business activities encompass research and development, manufacturing, sales and after‐sales services within the audiological care sector.

Sonova’s product portfolio is organized across two main segments. The Hearing Instruments division includes well‐known brands such as Phonak, Unitron and Hansaton, which offer a range of behind‐the‐ear, in‐the‐ear and custom hearing aids. Its Cochlear Implant Systems division, operating under the Advanced Bionics brand acquired in 2009, provides implantable devices and sound processors designed for individuals with severe to profound hearing impairment. Beyond product sales, Sonova offers fitting, support and repair services through an extensive network of audiology clinics, retail partners and distribution centers, ensuring comprehensive patient care from initial consultation through long‐term follow‐up.

With operations in over 100 countries, Sonova serves markets in Europe, North America, Asia‐Pacific, Latin America and the Middle East. The company maintains regional manufacturing facilities and research centers in Switzerland, Germany, the United States and China, alongside a global network of sales affiliates and authorized providers. Strategic acquisitions and partnerships have broadened Sonova’s geographic reach and strengthened its direct‐to‐consumer channels, reinforcing its position as a market leader in hearing healthcare.

Sonova’s leadership team, led by CEO Arnaud Nicoletti and supported by an experienced executive board, places strong emphasis on innovation, quality and corporate responsibility. The company invests a significant portion of revenues into R&D, focusing on advanced digital signal processing, wireless connectivity and miniaturization technologies. This commitment to technological advancement and patient‐focused service has underpinned Sonova’s growth and reputation as a trusted provider in the competitive global audiology industry.

Key Stats

• Today's Range: $58.20 to $58.65
• 50-Day Range: $58.00 to $68.08
• 52-Week Range: $52.83 to $77.56
• Volume: 60,845 shs
• Average Volume: 14,794 shs
• Market Capitalization: $17.36 billion
• P/E Ratio: N/A
• Dividend Yield: 1.08%
• Price Target: N/A
• Consensus Rating: Reduce

SONOVA Stock Analysis - MarketRank™

SONOVA scored higher than 51% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for SONOVA.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 22.58%

Earnings Growth

Earnings for SONOVA are expected to grow by 22.58% in the coming year, from $2.17 to $2.66 per share.

Price to Earnings Growth Ratio

SONOVA has a PEG Ratio of 2.28. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

SONOVA has a P/B Ratio of 5.73. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of SONOVA has been sold short.

Short Interest Ratio / Days to Cover

SONOVA has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SONOVA has recently decreased by 39.60%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

SONOVA pays a meaningful dividend of 1.08%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

SONOVA does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, SONOVA will have a dividend payout ratio of 23.68% next year. This indicates that SONOVA will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.00% of the float of SONOVA has been sold short.

Short Interest Ratio / Days to Cover

SONOVA has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SONOVA has recently decreased by 39.60%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 0.34

News Sentiment

SONOVA has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for SONOVA this week, compared to 1 article on an average week.

MarketBeat Follows

1 people have added SONOVA to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, SONOVA insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.01% of the stock of SONOVA is held by insiders.

Percentage Held by Institutions

Only 0.01% of the stock of SONOVA is held by institutions.

SONVY Stock Analysis - Frequently Asked Questions

How have SONVY shares performed this year?

SONOVA's stock was trading at $65.04 at the beginning of 2025. Since then, SONVY shares have decreased by 10.5% and is now trading at $58.24.

How do I buy shares of SONOVA?

Shares of SONVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Ex-Dividend for 7/2 Dividend: 6/16/2025
• Record date for 7/2 Dividend: 6/17/2025
• Dividend Payable: 7/02/2025
• Today: 7/13/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SONVY
• CIK: 1450681
• Web: www.sonova.com
• Phone: (158) 928-0101
• Fax: 41-58-928-2011
• Employees: 17,990
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 26.84
• P/E Growth: 2.28
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.45
• Current Ratio: 1.27
• Quick Ratio: 0.96

Sales & Book Value

• Annual Sales: $4.36 billion
• Price / Sales: 3.98
• Cash Flow: $3.41 per share
• Price / Cash Flow: 17.09
• Book Value: $10.16 per share
• Price / Book: 5.73

Miscellaneous

• Outstanding Shares: 298,134,000
• Free Float: 298,104,000
• Market Cap: $17.36 billion
• Optionable: Not Optionable
• Beta: 1.28